Detalles de la búsqueda
1.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579807
2.
Food Security and Food Sovereignty: The Difference Between Surviving and Thriving.
Health Promot Pract
; 24(6): 1075-1079, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877640
3.
Framing an Indigenous Food Sovereignty Research Agenda.
Health Promot Pract
; 24(6): 1117-1123, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877643
4.
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Am J Respir Crit Care Med
; 203(5): 553-564, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252985
5.
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment.
J Allergy Clin Immunol
; 148(1): 266-271.e2, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33609624
6.
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma.
J Asthma
; 58(4): 514-522, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859541
7.
Is the natural UV zone important for successful captive propagation of the Panther Chameleon (Furcifer pardalis); are different UVB irradiance exposures that generate a similar dose equally successful?
Zoo Biol
; 40(2): 150-159, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33559914
8.
Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies.
Respir Res
; 21(1): 128, 2020 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450869
9.
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
Respir Res
; 21(1): 131, 2020 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471423
10.
Health Promotion Programs and Policies in the Workplace: An Exploratory Study With Alaska Businesses.
Prev Chronic Dis
; 17: E125, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33059798
11.
COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy.
COPD
; 17(5): 477-484, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928003
12.
Barriers and bridges to implementing a workplace wellness project in Alaska.
Rural Remote Health
; 20(3): 5946, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660254
13.
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
Respir Res
; 20(1): 167, 2019 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31358008
14.
Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.
Ann Allergy Asthma Immunol
; 122(5): 478-485, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30802500
15.
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.
Eur Respir J
; 52(3)2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30220648
16.
Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology.
Pulm Pharmacol Ther
; 49: 67-74, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567116
17.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2128-2141, 2016 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27609406
18.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061907
19.
Chronic obstructive pulmonary disease in the long-term care setting: current practices, challenges, and unmet needs.
Curr Opin Pulm Med
; 23 Suppl 1: S1-S28, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990958
20.
Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Lung
; 195(6): 739-747, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993871